# Treatment-Resistant Depression Acquisitions Eli Lilly and Company Moves to Acquire AtaiBeckley By Kalin Ned | Published 2026-07-20 | Tech Source: Trend Hunter, https://www.trendhunter.com/trends/eli-lilly-and-company References: [prnewswire](https://www.prnewswire.com/news-releases/lilly-to-acquire-ataibeckley-to-advance-therapies-for-treatment-resistant-depression-and-other-mental-health-conditions-302827468.html)  [Eli Lilly and Company](https://www.trendhunter.com/trends/highperformance-computing-system) has entered into a definitive agreement to acquire AtaiBeckley, a clinical-stage biopharmaceutical company, in a transaction valued at approximately $2.8 billion in upfront cash consideration with an additional $1.0 billion in potential contingent value rights tied to specific development and regulatory milestones for its lead programs. AtaiBeckley's pipeline focuses on rapid-acting neuroplastogens designed to restore synaptic plasticity, the brain's ability to form and strengthen neural connections in regions critical to mood regulation. The lead asset, BPL-003, is a synthetic form of 5-MeO-DMT administered intranasally for treatment-resistant depression, which affects millions of people in the United States, and has demonstrated rapid and durable reductions in depressive symptoms following an in-clinic visit lasting approximately two hours, with beneficial effects persisting for months. This has led to Breakthrough Therapy Designation from the [FDA](https://www.trendhunter.com/trends/ct) and the initiation of Phase 3 activities. Image Credit: Eli Lilly and Company ## Trend Insights (Trend Hunter) - Score: 8.2/10 - Popularity: 74% | Activity: 88% | Freshness: 83% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [Science](https://www.trendhunter.com/science) ## Key Themes ### Why This Trend Is Growing - **Psychedelic-adjacent Neuroplastogens:** Synthetic compounds that promote synaptic plasticity are reshaping mental health pipelines by offering faster-acting alternatives to conventional antidepressants. - **In-clinic Depression Treatments:** Supervised administration models create space for premium care pathways that combine pharmaceutical efficacy with structured clinical oversight. - **Milestone-based Biotech Acquisitions:** Contingent value deal structures reflect growing appetite for high-risk neuroscience assets while linking acquisition upside to regulatory and development progress. ### Industries Being Reshaped - **Biopharmaceuticals:** Large drugmakers are expanding neuroscience portfolios through acquisitions of clinical-stage companies with differentiated mechanisms for hard-to-treat conditions. - **Mental Health Care:** Treatment-resistant depression demand is encouraging new service models built around rapid interventions, specialized monitoring, and long-duration patient outcomes. - **Clinical Research:** Late-stage trials for novel neuropsychiatric therapies are creating opportunities for sites, data platforms, and regulatory specialists focused on complex central nervous system studies. ## Related on Trend Hunter - [Personalized Neuromodulation Wearables](https://www.trendhunter.com/trends/cala-kiq-plus-device.md) - [Non-Invasive Brain Stimulation Clinics](https://www.trendhunter.com/trends/noninvasive-brain-stimulation.md) - [AI-Powered Drug Discovery Platforms](https://www.trendhunter.com/trends/bio-discovery-ai-platform.md) - [AI-Driven Discovery Platforms](https://www.trendhunter.com/trends/Pharma-AI-suite.md) - [Integrated Brain Health Centers](https://www.trendhunter.com/trends/integrated-brain-health.md) - [Prescription Digital Therapeutics](https://www.trendhunter.com/trends/ct.md) - [Resistance-Focused Cancer Therapies](https://www.trendhunter.com/trends/Resistance-focused-cancer-therapies.md) - [Medical-Grade Weight Management](https://www.trendhunter.com/trends/Medical-grade-weight-management.md) - [Bioactive AI Discovery Platforms](https://www.trendhunter.com/trends/Bioactive-AI-discovery-platforms.md)